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Hotspots in Neuro-Oncology
Michael Weller
From the Department of Neurology, University Hospital Zurich, Switzerland
 Peri-Ictal Pseudoprogression in Patients
with Brain Tumor
Rheims S, Ricard D, van den Bent M, et al. Neuro Oncol
2011; 13: 775–82.
In the July issue of Neuro-Oncology, another chapter was
published on the ongoing controversy of pseudoprogression
as a confounding factor when monitoring response to therapy:
Rheims and colleagues reported on a series of 10 brain tu-
mour patients who experienced pseudoprogression in the con-
text of epileptic seizures. These interesting observations in a
small number of patients illustrate the need to carefully assess
changes in the MRI scans shortly after epileptic seizures in
order to avoid the false diagnosis of progression.
 A Small-Molecule IAP Inhibitor Over-
comes Resistance to Cytotoxic Therapies
in Malignant Gliomas In Vitro and In Vivo.
Ziegler DS, Keating J, Kesari S, et al. Neuro Oncol 2011; 13:
820–9.
The August issue experienced a potential comeback of a cyto-
toxic therapy approach to malignant glioma that attracted a lot
of interest a few years ago, but gained much less attention
more recently. Inhibitors of apoptosis proteins (IAP) are
among the cellular defence mechanisms to prevent the bio-
chemical cascade of apoptosis involving caspase activation. It
has been tried to block cytoprotective IAP function in various
cancer models including gliomas, using different agents and
delivery approaches. Here, Ziegler and colleagues demon-
strate that the systemic treatment with a small-molecule IAP
inhibitor is feasible and active, in the apparent absence of sig-
nificant toxicity.
 Infratentorial Craniospinal Irradiation
for von Hippel-Lindau: a Retrospective
Study Supporting a New Treatment for
Patients with CNS Hemangioblastomas
Simone CB, Lonser RR, Ondos J, et al. Neuro Oncol 2011;
13: 1030–6.
Treatment options for patients with von Hippel-Lindau dis-
ease with diffuse CNS hemangioblastomas are very limited.
This report of 7 patients with 84 hemangioblastomas indicates
that infratentorial craniospinal irradiation to 43.2 Gy in 24
fractions offers a potentially reasonable treatment strategy
with complete resolution of some lesions and a decrease in the
growth rate and surgical interventions compared with histori-
cal controls.
 Morbidity and Mortality Following
Acoustic Neuroma Excision in the United
States: Analysis of Racial Disparities
During a Decade in the Radiosurgery Era
McClelland S, Guo H, Okuyemi KS. Neuro Oncol 2011; 13:
1252–9.
This article from the November issue is among the most pro-
vocative articles published in Neuro-Oncology in 2011. In es-
sence, data from a nationwide inpatient sample from 1994–
2003 revealed a postoperative mortality rate following acous-
tic neuroma surgery of 0.5 % and of an adverse discharge dis-
position of 6.1 %. Patients had a better outcome when they
were operated by high-caseload surgeons, had private insur-
ance, and were younger. There was a significant increase of
risk of death among African Americans. These data call for
reconsiderations of the current patterns of care of acoustic
neuromas in the US (and also for similar analyses in other
countries throughout the world).
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